ProRx Pharma Expands Production to Address Demand for Drugs on FDA Shortage List

Addition of Industry Veterans to Leadership Team Will Power Growth into Wellness and Longevity Sectors

EXTON, Pa., Feb. 27, 2025 /PRNewswire/ -- ProRx Pharma, the wellness and longevity 503B outsourcing facility, has announced the expansion of its operations to help meet the demand for critical medications—now and into the future with a full health, wellness, and longevity product line.

The company specializes in manufacturing products on the FDA's drug shortage list, such as semaglutide, offering medications to clinical centers, hospitals and pharmaceutical companies. ProRx is currently expanding its operations to a total of 6,888 square feet, doubling its existing 3,400-square-foot pharmaceutical and manufacturing facility. The new facility with more production space will allow ProRx to triple its manufacturing capabilities and enhance operational processes that will further strengthen compliance with compounding lab Standard Operating Procedures (SOPs) and the FDA.

"Compounding pharmacies play a critical role in the healthcare ecosystem in terms of meeting patients' demands for more accessible and affordable medications," said Kurt Lunkwitz, Chief Operating Officer at ProRx. "The new leadership team at ProRx not only has a wealth of industry experience, but also a shared vision for the company's future. The addition of these talented professionals means we will continue to be a 'disruptor' and redefine what it means to be a leader in the 503B pharmaceutical sector while staying firmly committed to exceeding the standards that are set by our industry."

As part of its strategic rebranding and expansion under new leadership, ProRx has welcomed several key additions to its operations teams, reinforcing its position as a leading wellness and longevity 503B outsourcing facility. The expanded team includes a new Vice President of Clinical Operations, who brings over 40 years of compounding experience across both 503A and 503B sectors. ProRx also recently welcomed a new head of its Quality Assurance unit, who previously served in the quality division of one of the top three global pharmaceutical companies, bringing invaluable expertise in compliance and product safety. Additionally, ProRx has partnered with one of the nation's top FDA compliance consulting firms, bringing over 25 years of proprietary industry experience working directly with the FDA. Collectively, the new team members contribute over 50 years of pharmaceutical and healthcare experience, further reinforcing ProRx's commitment to stringent regulatory compliance, quality assurance, and innovative wellness solutions.

The new leadership team—with 70-plus years of cumulative experience in the pharmaceutical and healthcare industries—acquired ProRx at the end of 2024 and immediately hired several highly skilled and well-respected professionals in quality control, pharmacy and FDA compliance. These strategic hires, together with an ongoing commitment to quality and compliance, aim to further enhance the company's operations and act as a driver for future growth, especially in the growing wellness and longevity markets.

"We are working closely with our clients, partners, and patients who depend on us for life-saving medicines. Together, we are addressing the critical drug shortages that affect our healthcare system today while also getting ready for the challenges of the future," said Lunkwitz.

ProRx is an FDA-registered cGMP facility and is currently licensed to provide compounded medications in 25 states and rapidly expanding coverage. In addition to manufacturing drugs on the FDA shortage list, the company offers pharmaceutical testing, formulation development, clinical supplies, and clinical trial FDA documentation.

About ProRx Pharma

ProRx Pharma is an FDA-registered cGMP facility focused on providing essential compounded medications to meet the need for medications on the FDA drug shortage list within the wellness and longevity sectors. The company produces customized products and formulations for medical institutions and physician offices, with a specialization in producing high-quality products to ensure patients have access to the medications they need during critical shortages. For more information, visit https://prorxpharma.com/

SOURCE ProRx Pharma